Literature DB >> 15007548

Persistence of candiduria in ICU catheterized patients is not linked to adherence and proteolytic activities of Candida strains.

Halis Akalin1, Beyza Ener, Ferda Kahveci, Sevim Akçağlar, Saban Gürcan, Okan Töre.   

Abstract

OBJECTIVE: In this study, the patients who developed asymptomatic candiduria in the intensive care unit were followed prospectively for the persistence of candiduria after the replacement of indwelling urethral catheter and the correlation between persistence and virulence factors (proteinase enzyme activity and epithelial adhesion) was assessed.
DESIGN: Prospective study.
SETTING: Intensive care unit and mycology laboratory at a university hospital. PATIENTS: Thirty-four patients with asymptomatic candiduria were included in the study.
RESULTS: Candiduria persisted in 19 of 34 patients(56%; group 1) and cleared in 15 of 34 patients(44%; group 2) after urinary catheters were changed. When the virulence factors (epithelial adhesion and proteinase activity) and distribution of Candida spp. were compared between two groups, no statistically significant correlation was found.
CONCLUSION: The host immune response might be more important than virulence factors of Candida spp. for persistence of candiduria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15007548     DOI: 10.1007/s00134-004-2223-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  13 in total

1.  Management of asymptomatic candiduria.

Authors:  J D Sobel
Journal:  Int J Antimicrob Agents       Date:  1999-05       Impact factor: 5.283

Review 2.  Fungal infections of the urinary tract.

Authors:  J D Sobel; J A Vazquez
Journal:  World J Urol       Date:  1999-12       Impact factor: 4.226

3.  Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group.

Authors:  C A Kauffman; J A Vazquez; J D Sobel; H A Gallis; D S McKinsey; A W Karchmer; A M Sugar; P K Sharkey; G J Wise; R Mangi; A Mosher; J Y Lee; W E Dismukes
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

4.  Fungal urinary tract infections in patients at risk.

Authors:  S Krcmery; M Dubrava; V Krcmery
Journal:  Int J Antimicrob Agents       Date:  1999-05       Impact factor: 5.283

5.  Immune response in patients with persistent candiduria and occult candidemia.

Authors:  G Talluri; V K Marella; D Shirazian; G J Wise
Journal:  J Urol       Date:  1999-10       Impact factor: 7.450

6.  International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program.

Authors:  M A Pfaller; D J Diekema; R N Jones; H S Sader; A C Fluit; R J Hollis; S A Messer
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

7.  Serum-proteins as nitrogen source for yeastlike fungi.

Authors:  F Staib
Journal:  Sabouraudia       Date:  1965-10

8.  Interleukin-4 and -10 exacerbate candidiasis in mice.

Authors:  L Tonnetti; R Spaccapelo; E Cenci; A Mencacci; P Puccetti; R L Coffman; F Bistoni; L Romani
Journal:  Eur J Immunol       Date:  1995-06       Impact factor: 5.532

9.  Correlation between cell-surface hydrophobicity of Candida albicans and adhesion to buccal epithelial cells.

Authors:  B Ener; L J Douglas
Journal:  FEMS Microbiol Lett       Date:  1992-11-15       Impact factor: 2.742

10.  In-vitro proteinase production by oral Candida albicans isolates from individuals with and without HIV infection and its attenuation by antimycotic agents.

Authors:  T Wu; L P Samaranayake; B Y Cao; J Wang
Journal:  J Med Microbiol       Date:  1996-04       Impact factor: 2.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.